Page last updated: 2024-10-28

hydroxychloroquine and Hyperglycemia

hydroxychloroquine has been researched along with Hyperglycemia in 3 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Hyperglycemia: Abnormally high BLOOD GLUCOSE level.

Research Excerpts

ExcerptRelevanceReference
"Hydroxychloroquine (HCQ) is a widely used antimalarial and anti-inflammatory drug and its hyperglycemia-controlling effect in diabetic patients is also under investigation."3.01Treating diabetes with combination of phosphodiesterase 5 inhibitors and hydroxychloroquine-a possible prevention strategy for COVID-19? ( Das, A; Koka, S; Kukreja, RC; Samidurai, A; Wang, R; Xi, L, 2023)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Kukreja, RC1
Wang, R1
Koka, S1
Das, A1
Samidurai, A1
Xi, L1
Brufsky, A1
Ceriello, A1

Reviews

2 reviews available for hydroxychloroquine and Hyperglycemia

ArticleYear
Treating diabetes with combination of phosphodiesterase 5 inhibitors and hydroxychloroquine-a possible prevention strategy for COVID-19?
    Molecular and cellular biochemistry, 2023, Volume: 478, Issue:3

    Topics: Animals; COVID-19; COVID-19 Drug Treatment; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type

2023
Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic.
    Journal of medical virology, 2020, Volume: 92, Issue:7

    Topics: Angiotensin-Converting Enzyme 2; Antibodies, Neutralizing; Antibody-Dependent Cell Cytotoxicity; Ant

2020

Other Studies

1 other study available for hydroxychloroquine and Hyperglycemia

ArticleYear
Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory.
    Diabetes research and clinical practice, 2020, Volume: 163

    Topics: Betacoronavirus; Blood Glucose; Coronavirus Infections; COVID-19; Humans; Hydroxychloroquine; Hyperg

2020